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An epidemiological study of RSV infection in the Gambia
Martin W. Weber,1, 2 Paul Milligan,1 Mariama Sanneh,1 Agnes Awemoyi,1 Raduwan Dakour,1
Gisela Schneider,4 Ayo Palmer,3 Mariatou Jallow,3 Anslem Oparaogu,1 Hilton Whittle,1 E. Kim Mulholland,1
& Brian M. Greenwood5, 1
Objective To describe the epidemiology of respiratory syncytial virus (RSV) infection in a developing country.
Methods The work was carried out in three hospitals for primary cases and in the community for secondary cases in the western region of
the Gambia, West Africa. RSV infection was diagnosed by immunofluorescence of nasopharyngeal aspirate samples in children younger
than two years admitted to hospital with acute lower respiratory infection (ALRI). Routine records of all children with ALRI were analysed,
and the incidence rates of ALRI, severe RSV-associated respiratory illness and hypoxaemic RSV infections were compared. A community-
based study was undertaken to identify secondary cases and to obtain information about spread of the virus.
Findings 4799 children with ALRI who were younger than two years and lived in the study area were admitted to the study hospitals:
421 had severe RSV-associated respiratory illness; 55 of these were hypoxaemic. Between 1994 and 1996, the observed incidence rate
for ALRI in 100 children younger than one year living close to hospital was 9.6 cases per year; for severe RSV-associated respiratory
illness 0.83; and for hypoxaemic RSV-associated respiratory illness 0.089. The proportion of all ALRI admissions due to RSV was 19%.
Overall, 41% of children younger than five years in compounds in which cases lived and 42% in control compounds had evidence of RSV
infection during the surveillance period.
Conclusion RSV is an important cause of ALRI leading to hospital admission in the Gambia. Morbidity is considerable and efforts at
prevention are worthwhile.
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Introduction
Respiratory syncytial virus (RSV) is the most important cause
of acute lower respiratory tract infections (ALRI) in early
childhood in industrialized countries (1–3). Outbreaks occur
annually during the winter months in temperate climates (1, 4,
5). A high proportion of children become infected when they
encounter the virus for the first time, and almost all children
become infected the second time (4, 6, 7).
In a study from Washington (DC), 40% of all RSV
infections in children in their first year of life involved the lower
respiratory tract, and 1% of infected infants had to be admitted
to hospital (4, 6). In a study from Houston, 33% of children
with an RSV infection had a lower respiratory tract infection,
and 1.6% had to be hospitalized (8). The sex distribution
among children with RSV infections severe enough to be
admitted to hospital in industrialized countries is 1.5–2:1
(boys:girls) (9–11), but the distribution between sexes inmilder
cases is more equal (5, 10, 12, 13).
Reinfection with RSV is common. A study in Tecumseh,
Michigan, found that 20% of children aged 5–9 years became
infected or reinfected within one year of the original episode
(14). The reinfection rate was 10% in children aged 15–19 years
and 3–6% in adults aged 20–50 years.
In developing countries, few studies have attempted to
quantify the importance of ALRI caused by RSV (15–20).
Reported incidence rates vary between 18 per 1000 children
younger than one year for hospitalization with RSV-associated
ALRI in Bedouins in southern Israel (18) to 198 per 1000 child-
years for children aged up to 18 months in a community-based
study from Colombia (15).
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To obtain more information about the importance of
RSV infection in developing countries, we started surveillance
for RSV in the western region of the Gambia in 1993. This
paper reports the epidemiology of RSV infection leading to
hospital admission and the spread of infection in the
community on the basis of data collected between 1993 and
1997.
Methods
Hospital surveillance
Surveillance for RSV disease was undertaken in the only three
hospitals in the western region of the Gambia that regularly
admit children with ALRI and at which oxygen is available:
. The Royal Victoria Hospital in Banjul on the coast, which is
the paediatric referral hospital for the western half of the
Gambia.
. The Medical Research Council Hospital in Fajara, approxi-
mately 15 km from Banjul, which serves a mainly periurban
population.
. Sibanor Mission Hospital, 80 km inland, which serves a
mainly rural population.
Surveillance started at the Royal Victoria andMedical Research
Council hospitals in October 1993 and in Sibanor in January
1994. For the purpose of this report, surveillance ended in
December 1997. Children admitted to the hospitals were
screened for RSV disease by study personnel if they presented
to hospital during working days (Monday to Friday), they had
an admission diagnosis of any formofALRI (as documented in
the case chart by the hospital physicians), they were younger
than two years and their guardians consented. Children who
were admitted overnight, at weekends or on public holidays
were screened the next working day, if they were available on
the ward for nasopharyngeal aspirates to be taken. Children
with clinical measles were not sampled. The clinical spectrum
of disease of these cases has been described (21).
At the same time, details of all ALRI admissions were
retrieved from the routine discharge records kept in the study
hospitals during the study.
Community study
A community study to obtain information about the spread of
RSV in the compounds in which infected children lived took
place in 1993–94. Compounds — in which members of an
extended family share a common central space and some social
tasks, such as cooking — are the usual unit of residence in the
Gambia.
As soon as a hospital identified a confirmed case of RSV
(the index case), a field worker visited the child’s compound
and obtained consent for a visit by a field team from the head of
the compound. The visit usually happened within one week of
the index case being admitted to hospital, and children younger
than five years were examined for evidence of respiratory
infections. If a respiratory infection — upper or lower — was
diagnosed, a nasopharyngeal aspirate was taken and trans-
ported on ice to the laboratory. Serum samples were taken on
the initial visit and on a final visit six weeks later. Between these
two visits, a field worker visited the compound twice a week
and took nasopharyngeal aspirate samples from any child who
had developed a respiratory tract infection since the previous
visit.
During 1993, only the compound inwhich the index case
lived was investigated in this way. During 1994, a neighbouring
compound was investigated in addition to the index case’s
compound, to obtain information about spread of RSV
between compounds.
Laboratory methods
RSV was detected by immunofluorescence (21). Serum
samples were assayed for neutralizing antibodies against RSV
with a microneutralization assay against RSV group A (Tracy
strain) and B (strain 18537) (22). Briefly, heat-inactivated sera
were diluted serially with Eagle’s minimum essential medium
(EMEM) with 2% fetal calf serum in 96-well, tissue-culture
plates, starting at a 3log2 dilution. RSV (50 ml + 100 tissue
culture infective dose (TCID)50) was added to each well.
Positive control wells contained medium rather than serum,
and negative control wells contained only medium. The
mixtures were incubated at 35 oC for 1 hour. After incubation,
100 ml of trypsinized HEp-2 cells (2–46104 cells) in EMEM
with 10% fetal calf serum was added to each well. The sealed
plates were maintained at 35 oC in an atmosphere of 5%
carbon dioxide. Twenty-four hours after the positive control
wells showed 100% cytopathic effect, the cells in all wells were
fixed with 10% formalin and stained with 1% crystal violet.
The neutralizing antibody titre was defined as the final serum
dilution at which a greater than 50% reduction in cytopathic
effect occurred. Reference sera were run with each batch for
standardization, and paired samples were run in the same
batch.
Statistical methods
Hospital admissions were included as cases of ALRI if the
hospital discharge book contained a discharge diagnosis of
ALRI. Children admitted with signs of ALRI and for whom
nasopharyngeal samples tested positive were classified as cases
of RSV infection. Hypoxaemic cases are a subgroup of RSV
cases in whom pulse oximetry shows that transcutaneous
haemoglobin oxygen saturation is less than 90%. The study
covered only part of 1993, so cases found in 1993 were
excluded from the hospital-based part of the study and when
the average annual incidence rate was calculated.
Incidence rates were calculated as the number of hospital
admissions per year divided by an estimate of the population at
risk. The numbers of children aged 0–1 years and 1–2 years in
each village for each year of the study were estimated from
1993 census data (Central Statistics Department, Department
of State for Finance and Economic Affairs, Banjul, The
Gambia) using Sprague coefficients (23) after smoothing in age
bands of five years by Arriaga’s method (24).
We allowed for population growth between 1993 and the
end of the study with projected figures to the final year of the
study, by applying the population growth rates for 1983–93 for
each local government area. The estimated population in the
catchment area for 1994 — the first year of the study — was
20 338 children younger than 1 year and 19 908 children aged
1–2 years. Poisson regression (or negative binomial regression
where there was overdispersion) was used to estimate
incidence rate ratios and 95% confidence intervals for the
effects of age, sex and transport cost to hospital. Transport cost
— the one-way transport fare for the usual means of public
transport (bus, boat or taxi) to the nearest hospital — was
estimated for each settlement in the western region of the
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Gambia (See Fig. 1). Estimates of incidence rate ratios were
adjusted for effects of population density and residence in an
urban or rural area by including appropriate variables in the
regression models.
Cumulative incidence rates of RSV infection for case and
control compounds during six weeks of follow-up were
compared by using conditional logistic regression. Detection
of RSV in a nasopharyngeal aspirate or a twofold increase in
titre between paired serum samples was considered to be
evidence of infection. Analyses were performed using Stata
version 6 (Statacorp, Texas).
The study was approved by the Gambian Government
and Medical Research Council Laboratories Ethical Commit-
tee. All treatments given corresponded to the best medical care
available in the Gambia.
Results
Hospital admissions
During the years 1994–97, 5557 children under two years of
age admitted to one of the three study hospitals had a
documented discharge diagnosis of ALRI. Of these, 301 had
no village of origin documented, 423 came from outside the
western region and 34 had no sex documented. Overall,
4799 children with ALRI were included in the study. Of these,
392 had an additional diagnosis of measles (314 of these cases
occurred in 1997).
Nasopharyngeal aspirates were taken from 2252 (47%)
of the children included in the study. Reasons for a sample not
being taken included the child being admitted during weekends
or holidays, absence of the patient from the ward for
investigations and lack of documentation of an admission
diagnosis on the patient’s chart.
During the study period, 421 children younger than two
years who lived in the study area were admitted to hospital with a
documented RSV infection. Fig. 2 shows the seasonality of
ALRI admissions with a peak in the rainy season. The monthly
number of children with clinical measles is also included (Fig. 2).
The observed incidence rates for hospital admissions of
children with ALRI, severe RSV-associated respiratory illness
and RSV-associated respiratory illness with hypoxaemia were
highest in areas closest to the study hospitals (Fig. 3). Between
1994 and 1996, the average observed incidence of hospital
admissions for children younger than one year living in Banjul
with ALRI was 5.27 per 100 child-years; with RSV-associated
severe respiratory illness 0.87 per 100 child-years; andwith RSV-
associated hypoxaemia was 0.11 per 100 child-years. For the
rural district of Foni BintangKaranai, which is closest to Sibanor
Mission Hospital, the respective values were 16.0, 1.77 and 0.2
per 100 child-years. Observed incidence rates decreased as the
costs of transport to hospital increased (Fig. 3; Table 1). The
observed incidence rates in 1997were lower than the average for
the individual years 1994–96; the incidence rate ratio
(1997:1994–96) for ALRI was 0.82, for severe RSV infection
0.32 and for RSV-associated hypoxaemia 0.27.
Incidence rates for ALRI were significantly (p<0.05)
higher in males, younger children, children from rural
settlements and especially children from smaller rural settle-
ments (Table 1). Severe RSV-associated respiratory illness
followed a similar pattern, but the increase in incidence rates
for children from smaller and rural settlements was less
pronounced. The incidence of hypoxaemic RSV-associated
respiratory illness varied with age but was not associated
significantly with sex or distance from hospital, and the
incidence was only slightly higher in children from small rural
settlements than in those in other groups. Incidence rate ratios
for a variety of factors are shown in Table 1.
Overall, 18.7% of children with ALRI from whom
nasopharyngeal aspirates were taken (47% of cases) tested
positive for RSV.
Measles cases
In the first half of 1997, a measles outbreak affected the study
area (Fig. 2). We excluded from the calculations presented
above ALRI cases associated with measles in which the child
was admitted to hospital. For measles, the observed incidence
rate of hospital admissions in children younger than one year
for whom the transport fare to the hospital was 2 dalasis or less
was 1.1 cases per 100 child-years. The incidence rate ratio for
an increase in taxi fare of 1 dalasi was 0.74 (95% CI 0.69–0.78)
and for the second year of life compared with the first was
0.44 (0.34–0.56). Boys had severe measles more often than
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girls (incidence rate ratio 1.23, 95% CI 0.98–1.56), but the
finding was of borderline significance.
Household study
During 1993, visits were made to compounds in which
81 index cases lived and in 1994, visits were made to 22 case
compounds and 22 neighbouring control compounds. The
mean numbers of children younger than 5 years were 5.2
(SD 3.5) and 5.1 (SD 3.0) for case and control compounds,
respectively. Nasopharyngeal aspirate samples and paired
serum samples were taken from 237 children in case
compounds and 83 children in control compounds. The
mean age of children in each of these groups was 29 (SD 17)
months. In 85 (27%) of the 320 children studied there was
an elevated antibody titre or virus was detected by
immunofluorescence.
During 1993, when only case compounds were studied,
14% of the children had evidence of infection with RSV. In
1994, 41% of the children in the case compounds and 42% of
those from control compounds had evidence of RSV infection
(matched odds ratio 1.66, 95% CI 0.39–6.97). The rate of
infection in individual compounds ranged from 0% to 100%.
Infection rates were lowest in children aged 2–3 years (16%)
and highest in children aged 0–1 and 4–5 years (33%).
Incidence rates of infection did not differ significantly between
case and control compounds or between age groups.
Discussion
The results of a household study showed that RSV circulated
widely in the community during outbreaks of RSV in the
Gambia. A considerable number of children in the compounds
we investigated had evidence of recent infection. This figure is
likely to be an underestimate, because compounds were visited
only after an index case — usually a young infant — was
admitted to hospital. It is possible that compounds were visited
when the number of new cases was already declining, so the total
number of infected children in the compounds visited may have
been as much as double the number that we observed.
The study started during an RSV outbreak in 1993, and
so more compounds were visited towards the end than the
start of the outbreak. This might explain the lower number of
infected children compared with that for the next year. In
community-based studies in industrialized countries, infection
rates of between 69% and 98% have been observed during the
first year of life, with little or no decline in rates in the second
year of life (8, 25).Monto found a yearly infection rate of 19.7%
in children aged 5–9 years (14). In a family study, Hall reported
an overall infection rate of 29% for infants and 63% for
children within infected families (26).
Distance from hospital
In the hospital-based part of the study, we showed that the
further a child with ALRI or RSV-associated severe respiratory
illness lived from the hospital, the less likely they were to be
admitted to hospital. Encouragingly, and to our surprise, this
effect was less noticeable for children with hypoxaemic RSV-
associated respiratory illness. As the three study hospitals are
the only ones in the western region that provide oxygen, this
finding indicates that the referral system worked best for the
most severe cases of infection.
The influence of distance — or the expense associated
with it — on the observed incidence of disease in health
facilities was marked, and would appear obvious. It is
surprising, therefore, how rarely investigators have adjusted
for distance in previous studies (27, 28). We used transport
fares rather than distance, as we believed that they best reflect
the actual obstacle to seeking health care in situations where
most patients have to use public transport. Our finding
indicates that the need to spendmore than aminimum amount
on transport (2 dalasis = US$ 0.20) directly translates into
reduced access to health services, which will mainly affect the
poor.
The incidence rate for admission to hospital of children
with ALRI who were younger than one year and who lived in
compounds near to health facilities was around 10% per year
— lower than that reported in other studies (15, 19, 29–32).
The children in our study represented only themore severe end
of the spectrum of ALRI, however — cases severe enough to
be admitted to hospital despite pressures on hospital beds.
Severe RSV-associated illness
The incidence of severe RSV-associated respiratory illness that
we observed is likely to be a substantial underestimate. Samples
were taken from only half the children with ALRI, and in those
we are likely to have missed an additional number of cases, as
diagnosis with immunofluorescence alone has limited sensi-
tivity (33, 34). The transport of samples from distant health
facilities may have further decreased the yield.
On the basis of the proportion of children from whom
nasopharyngeal samples were taken, we estimate that the real
incidence of admissions with severe RSV-associated ALRI is
over 3% per year in children younger than one year. This is
similar to the incidence reported for Alaskan Natives (35), but
higher than that reported in Bedouins from southern Israel (18).
Factors affecting incidence rates
We found a higher incidence of ALRI in boys than in girls
— an almost universal finding in ALRI. Observed incidence
rates for ALRI and RSV-associated respiratory illness were
higher in rural settings than in urban settings and in small
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villages than in large villages. Most small villages are poorer
than large ones, and this might indicate the influence of
overall living standard on the incidence of ALRI. The effect
of this influence was less pronounced in groups of children
with severe RSV infection.
An interesting finding is the low number of RSV cases
observed in 1997, after three years of regular large outbreaks. It
is intriguing that this coincided with an increasing number of
measles cases in the community, after several years without any
measles cases. It is possible that some degree of cross-protection
exists between RSV and the measles virus, which are both
paramyxoviruses (36). A recent report showing that hospitaliza-
tion rates in children with RSV in the United States increased
over twofold between 1980 and the time of writing could point
in the same direction, as this increase happened when measles
vaccination was controlling measles effectively (37).
Conclusion
We have shown that RSV is an important cause of cases of
ALRI severe enough to lead to hospital admission in the
Gambia. It is not possible to estimate the burden of mortality
due to RSV in our study, but morbidity is considerable and
efforts at prevention are likely to be worthwhile. n
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Re´sume´
Etude e´pide´miologique de l’infection a` VRS en Gambie
Objectif De´crire l’e´pide´miologie de l’infection par le virus
respiratoire syncytial (VRS) dans un pays en de´veloppement.
Me´thodes L’e´tude a e´te´ re´alise´e dans trois hoˆpitaux pour les cas
primaires et dans la communaute´ pour les cas secondaires dans la
partie occidentale de la Gambie, en Afrique de l’Ouest. L’infection a`
VRS a e´te´ diagnostique´e par immunofluorescence sur des
e´chantillons rhinopharynge´s pre´leve´s par aspiration chez des
enfants de moins de 2 ans hospitalise´s pour une infection aigue¨ des
voies respiratoires infe´rieures. Les dossiers de tous les enfants
atteints d’infections aigue¨s des voies respiratoires infe´rieures ont
e´te´ analyse´s et les taux d’incidence de ces infections, des maladies
respiratoires graves associe´es au VRS et des infections a` VRS avec
hypoxe´mie ont e´te´ compare´s. Une e´tude dans la communaute´ a e´te´
re´alise´e pour identifier les cas secondaires et obtenir des
informations sur la propagation du virus.
Re´sultats Parmi les enfants de moins de 2 ans re´sidant dans
la zone d’e´tude, 4799 ont e´te´ admis dans les hoˆpitaux de
l’e´tude pour une infection aigue¨ des voies respiratoires
Table 1. Incidence rate ratios for different variables that influence the incidence of hospital admission in children with all ALRI
(excluding measles), severe RSV infection and hypoxaemic RSV infection during 1994–96
Variables Incidence rate ratio (95% CI)
All ALRI RSV infection Hypoxaemic RSV infection
Transport cost (dalasis)
0–2 1 1 1
3–5 0.31 (0.29–0.34) 0.51 (0.39–0.65) 0.88 (0.40–1.94)
6–10 0.089 (0.078–0.10) 0.26 (0.18–0.38) 0.39 (0.13–1.19)
11–15 0.036 (0.027–0.049) 0.14 (0.07–0.28) 0.39 (0.09–1.70)
>15 0.008 (0.004–0.015) 0.03 (0.008–0.14) 0.15 (0.02–1.35)
Sex
Female 1 1 1
Male 1.23 (1.16–1.32) 1.26 (1.03–1.55) 1.58 (0.89–2.80)
Age (months)
0–11 1 1 1
12–23 0.55 (0.51–0.59) 0.33 (0.26–0.41) 0.22 (0.11–0.46)
Settlement type and size
Urban 1 1 1
Rural51000 inhabitants 1.89 (1.73–2.07) 1.23 (0.93–1.62) 1.1 (0.51–2.37)
Rural <1000 inhabitants 2.92 (2.65–3.21) 1.65 (1.19–2.28) 2.37 (1.04–5.41)
ALRI = acute lower respiratory tract infection.
RSV = respiratory syncytial virus.
CI = confidence interval.
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infe´rieures : 421 pre´sentaient une maladie respiratoire grave
associe´e au VRS, avec hypoxe´mie pour 55 d’entre eux. Entre
1994 et 1996, le taux d’incidence observe´ des infections
aigue¨s des voies respiratoires infe´rieures chez 100 enfants de
moins d’un an re´sidant a` proximite´ de l’hoˆpital e´tait de 9,6 cas
par an ; il e´tait de 0,83 pour les maladies respiratoires graves
associe´es au VRS et de 0,089 pour les maladies respiratoires
associe´es au VRS avec hypoxe´mie. Par rapport a` l’ensemble des
cas d’infections aigue¨s des voies respiratoires infe´rieures, ceux
dus au VRS repre´sentaient 19 %. Au total, 41 % des enfants de
moins de 5 ans re´sidant dans le meˆme quartier que les cas et
42 % de ceux des quartiers te´moins ont pre´sente´ des signes
d’infection a` VRS pendant la pe´riode faisant l’objet de la
surveillance.
Conclusion Le VRS est une cause importante d’infections aigue¨s
des voies respiratoires infe´rieures conduisant a` une hospitalisation
en Gambie. Il entraıˆne une morbidite´ conside´rable et les efforts de
pre´vention sont justifie´s.
Resumen
Estudio epidemiolo´gico de la infeccio´n por el VRS en Gambia
Objetivo Describir la epidemiologı´a de la infeccio´n por el virus
respiratorio sincitial en un paı´s en desarrollo.
Me´todos El trabajo se llevo´ a cabo en tres hospitales para los casos
primarios y en la comunidad para los casos secundarios, en la regio´n
occidental de Gambia, A´frica occidental. Los casos de infeccio´n por el
VRS fueron diagnosticados mediante inmunofluorescencia de
muestras del aspirado nasofarı´ngeo en los nin˜os menores de dos
an˜os ingresados en el hospital con infeccio´n aguda de las vı´as
respiratorias inferiores (IAVRI). Se analizaron los registros ordinarios
de todos los nin˜os con IAVRI, compara´ndose las tasas de incidencia
de IAVRI, enfermedad respiratoria grave asociada al VRS e
infecciones hipoxe´micas por el VRS. Se emprendio´ un estudio
comunitario para identificar los casos secundarios y obtener
informacio´n sobre la propagacio´n del virus.
Resultados En los hospitales en cuestio´n ingresaron 4799 me-
nores de dos an˜os con IAVRI que vivı´an en la zona estudiada:
421 sufrı´an trastornos respiratorios graves asociados al VRS, y de
ellos 55 presentaban hipoxemia. Entre 1994 y 1996, la tasa de
incidencia observada para las IAVRI en 100 nin˜os menores de un
an˜o que vivı´an cerca del hospital fue de 9,6 casos anuales, para la
enfermedad respiratoria grave asociada al VRS fue de 0,83, y para
la enfermedad respiratoria hipoxe´mica asociada al VRS, de 0,089.
La proporcio´n de ingresos por IAVRI debidos al VRS fue del 19%.
Globalmente, el 41% de los menores de cinco an˜os de los
complejos de viviendas en que habitaban los casos y el 42% de los
complejos de control mostraron signos de infeccio´n por el VRS
durante el periodo de vigilancia.
Conclusio´n El VRS es una causa importante de los casos de IAVRI
que acaban siendo hospitalizados en Gambia. Dada esa
considerable morbilidad, las actividades de prevencio´n esta´n
justificadas.
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